BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26343749)

  • 1. Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy.
    Uchino M; Ikeuchi H; Bando T; Hirose K; Hirata A; Chohno T; Sasaki H; Horio Y; Takahashi Y; Takesue Y; Hida N; Hori K; Nakamura S
    Digestion; 2015; 92(3):147-55. PubMed ID: 26343749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.
    Barreiro-de Acosta M; García-Bosch O; Souto R; Mañosa M; Miranda J; García-Sanchez V; Gordillo J; Chacon S; Loras C; Carpio D; Maroto N; Menchén L; Rojas-Feria M; Sierra M; Villoria A; Marin-Jimenez I;
    Inflamm Bowel Dis; 2012 May; 18(5):812-7. PubMed ID: 21826765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study.
    Segal JP; Penez L; Mohsen Elkady S; Worley GHT; McLaughlin SD; Mullish BH; Quraishi MN; Ding NS; Glyn T; Kandiah K; Samaan MA; Irving PM; Faiz OD; Clark SK; Hart AL
    Scand J Gastroenterol; 2018 Sep; 53(9):1051-1058. PubMed ID: 30270685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
    Huguet M; Pereira B; Goutte M; Goutorbe F; Dubois A; Bommelaer G; Buisson A
    Inflamm Bowel Dis; 2018 Jan; 24(2):261-268. PubMed ID: 29361101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.
    Selvasekar CR; Cima RR; Larson DW; Dozois EJ; Harrington JR; Harmsen WS; Loftus EV; Sandborn WJ; Wolff BG; Pemberton JH
    J Am Coll Surg; 2007 May; 204(5):956-62; discussion 962-3. PubMed ID: 17481518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.
    Verstockt B; Claeys C; De Hertogh G; Van Assche G; Wolthuis A; D'Hoore A; Vermeire S; Ferrante M
    United European Gastroenterol J; 2019 Nov; 7(9):1215-1225. PubMed ID: 31700634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal pouch complications in patients who underwent restorative proctocolectomy for ulcerative colitis and familial adenomatous polyposis in 1985-2008.
    Burdyński R; Banasiewicz T; Marciniak R; Biczysko M; Szmeja J; Paszkowski J; Grochowalski M; Maik J; Majewski P; Krokowicz P; Drews M
    Pol Przegl Chir; 2011 Mar; 83(3):161-70. PubMed ID: 22166319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis.
    Viscido A; Habib FI; Kohn A; Papi C; Marcheggiano A; Pimpo MT; Vernia P; Cadau G; Caprilli R
    Aliment Pharmacol Ther; 2003 May; 17(10):1263-71. PubMed ID: 12755839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.
    Barreiro-de Acosta M; García-Bosch O; Gordillo J; Mañosa M; Menchén L; Souto R; Marin-Jimenez I;
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):756-8. PubMed ID: 22395225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome.
    Madiba TE; Bartolo DC
    J R Coll Surg Edinb; 2001 Dec; 46(6):334-7. PubMed ID: 11768572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.
    Selvaggi F; Pellino G; Canonico S; Sciaudone G
    Inflamm Bowel Dis; 2015 Jan; 21(1):79-92. PubMed ID: 25517596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.
    Iizuka M; Etou T; Yagisawa H; Ishii T; Sagara S
    Intern Med; 2014; 53(22):2581-3. PubMed ID: 25400178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: the management of pouchitis.
    Pardi DS; Sandborn WJ
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1087-96. PubMed ID: 16611268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Matalon S; Elad H; Brazowski E; Santo E; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Mar; 21(3):589-95. PubMed ID: 25659085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications after ileal pouch-anal anastomosis.
    Stein RB; Lichtenstein GR
    Semin Gastrointest Dis; 2000 Jan; 11(1):2-9. PubMed ID: 10706224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
    Van Assche G; Ferrante M; Vermeire S; Noman M; Rans K; Van der Biest L; Penninckx F; Wolthuis A; Rutgeerts P; D'Hoore A
    Colorectal Dis; 2012 Apr; 14(4):e181-6. PubMed ID: 21951549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis.
    Kelly OB; Rosenberg M; Tyler AD; Stempak JM; Steinhart AH; Cohen Z; Greenberg GR; Silverberg MS
    J Crohns Colitis; 2016 Apr; 10(4):410-7. PubMed ID: 26721938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis.
    Suzuki H; Ogawa H; Shibata C; Haneda S; Watanabe K; Takahashi K; Funayama Y; Sasaki I
    Dis Colon Rectum; 2012 Mar; 55(3):330-6. PubMed ID: 22469801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab)].
    Semb S; Nordgaard-Lassen I
    Ugeskr Laeger; 2008 Dec; 170(50):4134-5. PubMed ID: 19091194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis.
    Uchino M; Ikeuchi H; Bando T; Hirata A; Chohno T; Sasaki H; Horio Y; Nakamura S
    J Anus Rectum Colon; 2017; 1(4):106-111. PubMed ID: 31583309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.